292 related articles for article (PubMed ID: 18408765)
21. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
[TBL] [Abstract][Full Text] [Related]
22. The roles of Cdk5-mediated subcellular localization of FOXO1 in neuronal death.
Zhou J; Li H; Li X; Zhang G; Niu Y; Yuan Z; Herrup K; Zhang YW; Bu G; Xu H; Zhang J
J Neurosci; 2015 Feb; 35(6):2624-35. PubMed ID: 25673854
[TBL] [Abstract][Full Text] [Related]
23. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation.
Matsuzaki H; Daitoku H; Hatta M; Aoyama H; Yoshimochi K; Fukamizu A
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11278-83. PubMed ID: 16076959
[TBL] [Abstract][Full Text] [Related]
24. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.
Perrot V; Rechler MM
Mol Endocrinol; 2005 Sep; 19(9):2283-98. PubMed ID: 15890677
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
Wu Z; Sun H; Zeng W; He J; Mao X
PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
[TBL] [Abstract][Full Text] [Related]
26. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.
Hu MC; Lee DF; Xia W; Golfman LS; Ou-Yang F; Yang JY; Zou Y; Bao S; Hanada N; Saso H; Kobayashi R; Hung MC
Cell; 2004 Apr; 117(2):225-37. PubMed ID: 15084260
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of islet-1 serine 269 by CDK1 increases its transcriptional activity and promotes cell proliferation in gastric cancer.
Shi Q; Ni X; Lei M; Xia Q; Dong Y; Zhang Q; Wang W
Mol Med; 2021 May; 27(1):47. PubMed ID: 33962568
[TBL] [Abstract][Full Text] [Related]
28. KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
Zhong Y; Yang J; Xu WW; Wang Y; Zheng CC; Li B; He QY
Oncogene; 2017 Nov; 36(44):6177-6189. PubMed ID: 28869606
[TBL] [Abstract][Full Text] [Related]
29. Hcm1 integrates signals from Cdk1 and calcineurin to control cell proliferation.
Arsenault HE; Roy J; Mapa CE; Cyert MS; Benanti JA
Mol Biol Cell; 2015 Oct; 26(20):3570-7. PubMed ID: 26269584
[TBL] [Abstract][Full Text] [Related]
30. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.
Scheijen B; Ngo HT; Kang H; Griffin JD
Oncogene; 2004 Apr; 23(19):3338-49. PubMed ID: 14981546
[TBL] [Abstract][Full Text] [Related]
31. FOXO1 is a tumor suppressor in cervical cancer.
Zhang B; Gui LS; Zhao XL; Zhu LL; Li QW
Genet Mol Res; 2015 Jun; 14(2):6605-16. PubMed ID: 26125868
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis.
Gan L; Liu P; Lu H; Chen S; Yang J; McCarthy JB; Knudsen KE; Huang H
Cell Death Differ; 2009 Oct; 16(10):1408-17. PubMed ID: 19575018
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of FoxO1 acetylation by INHAT subunit SET/TAF-Iβ induces p21 transcription.
Chae YC; Kim KB; Kang JY; Kim SR; Jung HS; Seo SB
FEBS Lett; 2014 Aug; 588(17):2867-73. PubMed ID: 24983498
[TBL] [Abstract][Full Text] [Related]
34. FoxO1 enhances differentiation and apoptosis in human primary keratinocytes.
Shi G; Liao PY; Cai XL; Pi XX; Zhang MF; Li SJ; Quan JH; Fan YM
Exp Dermatol; 2018 Nov; 27(11):1254-1260. PubMed ID: 30144329
[TBL] [Abstract][Full Text] [Related]
35. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
Yang Y; Hou H; Haller EM; Nicosia SV; Bai W
EMBO J; 2005 Mar; 24(5):1021-32. PubMed ID: 15692560
[TBL] [Abstract][Full Text] [Related]
36. PCAF represses transactivation function of FOXO1 in an acetyltransferase-independent manner.
Yoshimochi K; Daitoku H; Fukamizu A
J Recept Signal Transduct Res; 2010 Feb; 30(1):43-9. PubMed ID: 20041807
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
[TBL] [Abstract][Full Text] [Related]
38. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification.
Hosaka T; Biggs WH; Tieu D; Boyer AD; Varki NM; Cavenee WK; Arden KC
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2975-80. PubMed ID: 14978268
[TBL] [Abstract][Full Text] [Related]
39. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.
Lynch RL; Konicek BW; McNulty AM; Hanna KR; Lewis JE; Neubauer BL; Graff JR
Mol Cancer Res; 2005 Mar; 3(3):163-9. PubMed ID: 15798096
[TBL] [Abstract][Full Text] [Related]
40. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
